Timeline Mitopure vs Tru Niagen: Which Is Better in 2026?

These are different tools for different goals, so pick by outcome. Choose Timeline Mitopure ($100, 500mg urolithin A) if your concern is age-related muscle decline. It stands out because placebo-controlled human trials show urolithin A can improve muscle strength and endurance, a functional result rather than just a moved biomarker. That is unusually strong evidence for this category, and it justifies the premium for active adults over 40. Choose Tru Niagen ($44, 300mg Niagen NR) if you want the most-studied NAD+ precursor with the deepest safety record: 30+ human trials, reliable 40 to 50% NAD+ increases, and none of the regulatory uncertainty currently surrounding NMN. Its catch is honesty: raising NAD+ is well documented, but clinical anti-aging outcomes in humans are still emerging. So Mitopure is the pick when you want a measured functional benefit and will pay for it; Tru Niagen is the safer, cheaper, well-characterized foundation. Neither reverses aging or is proven to extend lifespan. Treat both as evidence-informed wellness bets, not medicine.

The honest starting point is that these supplements work through different mechanisms. Mitopure delivers urolithin A, a compound that supports mitophagy, the cellular recycling of worn-out mitochondria. Most people's gut microbiomes produce little urolithin A from food, so direct supplementation is the reliable route. Tru Niagen delivers nicotinamide riboside (NR), an NAD+ precursor that raises circulating NAD+ levels your cells use for energy metabolism.

The evidence profiles differ in kind:

Mitopure's trials point to a functional endpoint (muscle performance), while Tru Niagen's data most reliably shows it does what it says biochemically, lifting NAD+, with translation to felt benefits still emerging. On regulatory footing, NR sits on settled ground, unlike NMN, whose FDA status remains unsettled. Cost over a year is stark: roughly $1,200 for Mitopure versus about $530 for Tru Niagen. Neither produces fast, stimulant-like effects; both ask for months of consistent use.

Choose Mitopure if you are an active adult or athlete focused on muscle strength and endurance, especially past 40 when sarcopenia becomes a real concern. It carries the strongest human functional evidence in the longevity-supplement space, and you accept the premium price.

Choose Tru Niagen if you want a safe, deeply studied NAD+ precursor as a long-term cellular-health foundation, prefer avoiding NMN's regulatory question mark, and value a lower monthly cost.

Consider both, or neither, if budget is tight; they target different systems, so there is no single winner, and neither is proven to extend human lifespan.

Honest tradeoff: expectations matter more than the label here. Neither supplement produces noticeable day-to-day changes, and the human healthspan payoff for this whole category remains unproven. Mitopure's edge is a measured functional outcome; Tru Niagen's edge is evidence depth and peace of mind. Match the one you buy to the specific goal you care most about, and commit to a few months before judging it.